| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.7B | $27.8B | $25.5B | $21.2B | $20.5B | $20.7B | $6.3B | $6.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | $1.3B | $1.2B |
| R&D Expense | $0.6B | $0.6B | $0.7B | $0.6B | $0.5B | $0.6B | $0.7B | $0.7B |
| SG&A Expense | $2.4B | $2.5B | $2.6B | $2.5B | $2.5B | $2.4B | $2.8B | $2.7B |
| Operating Income | — | $3.1B | $2.3B | $1.2B | $1.3B | $-16.0B | $1.1B | $0.7B |
| Net Income | $2.6B | $3.0B | $1.9B | $-0.6B | $-0.2B | $-9.9B | $0.0B | $0.1B |
| EPS (Basic) | — | $3.00 | $1.93 | — | — | $-14.73 | $0.07 | $0.28 |
| EPS (Diluted) | — | $2.98 | $1.91 | $-0.61 | $-0.27 | $-14.73 | $0.07 | $0.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $40.9B | $38.4B | $36.9B | $34.2B | $35.3B | $38.0B | $53.4B | $52.4B |
| Current Assets | $18.8B | $17.2B | $16.3B | $14.6B | $15.1B | $16.5B | $15.2B | $15.0B |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $13.9B | $13.0B | $13.0B | $11.1B | $9.1B | $10.2B | $10.0B | $9.0B |
| Stockholders' Equity | $18.8B | $16.9B | $15.4B | $14.4B | $14.8B | $12.9B | $21.9B | $17.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.8B | $3.3B | $3.1B | $1.9B | $2.4B | $1.3B | $2.1B | $1.8B |
| Investing Cash Flow | $-2.0B | $-1.0B | $-0.8B | $-1.6B | $-0.5B | $-0.6B | $-1.0B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.5B | $-1.5B | $-2.0B | $-1.6B | $-2.1B | $0.2B | $-1.5B | $-4.4B |